-
公开(公告)号：EP0200383A3
公开(公告)日：1987-09-02
申请号：EP86302537
申请日：1986-04-07
摘要： A treatment of diabetes mellitus is described. The method comprises administering, via the nasal mucous membrane of a patient having diabetes mellitus, a pharmaceutically acceptable amount of an alkali metal salt, the ammonium salt, or the free acid of a substantially zinc-free insulin, optionally in the presence of an absorption enhancing agent.
-
公开(公告)号：EP0200383A2
公开(公告)日：1986-12-10
申请号：EP86302537.5
申请日：1986-04-07
摘要： A treatment of diabetes mellitus is described. The method comprises administering, via the nasal mucous membrane of a patient having diabetes mellitus, a pharmaceutically acceptable amount of an alkali metal salt, the ammonium salt, or the free acid of a substantially zinc-free insulin, optionally in the presence of an absorption enhancing agent.
摘要翻译： 描述了糖尿病的治疗。 该方法包括经由患有糖尿病的患者的鼻粘膜施用药学可接受量的碱金属盐，铵盐或基本上无锌的胰岛素的游离酸，任选地在吸收存在下 增强剂。
-
公开(公告)号：EP0047122A3
公开(公告)日：1983-01-26
申请号：EP81303870
申请日：1981-08-25
IPC分类号： A61K09/00 , A61K31/415 , C07D235/30
CPC分类号： A61K31/415 , A61K9/0043
摘要： Intranasal formulations for antiviral benzimidazole compounds are disclosed. The formulations contain the active ingredient; a non-ionic, surface-active agent with a HLB number from 12 to 16; and a propellant.
-
公开(公告)号：EP0047122A2
公开(公告)日：1982-03-10
申请号：EP81303870.0
申请日：1981-08-25
IPC分类号： A61K9/00 , A61K31/415 , C07D235/30
CPC分类号： A61K31/415 , A61K9/0043
摘要： Intranasal formulations for antiviral benzimidazole compounds are disclosed. The formulations contain the active ingredient; a non-ionic, surface-active agent with a HLB number from 12 to 16; and a propellant.
摘要翻译： 公开了用于抗病毒苯并咪唑化合物的鼻内制剂。 制剂含有活性成分; HLB为12至16的非离子表面活性剂; 和推进剂。
-
-
-
搜索结果
4 条记录 (耗时 0.009 秒)
